First-to-Market Edge for Apellis’s Syfovre in Geographic Atrophy Diminished in the Face of an…
Exton, Pennsylvania, July 28, 2023 (GLOBE NEWSWIRE) -- For many who have been following the retina market, the news about the emerging safety signal associated with Apellis’ Syfovre in geographic atrophy (GA) feels very similar to the…